FDA issued a Warning Letter to Abbott Molecular on 8/12/2009 for a previous inspection.
483 Abbott Molecular May 2011

483 Abbott Molecular May 2011

Christopher Leach FDA, Nicole Williams FDA$119.00 - Available Now

FDA investigators audited the Abbott Molecular - Des Plaines, IL, United States facility and issued inspectional observations (via FDA 483) on 24 May 2011.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 24 May 2011
  • Location: Des Plaines, United States
  • FEI: 3005248192
Add To Cart